Ofloxacin Ear Drops Suppliers & Bulk Manufacturers
Available Forms: Ear drops
Available Strengths: 0.3%
Reference Brands: Floxin Otic(US)
Category:
ENT
Ofloxacin ear drops are a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, preventing bacterial replication. They effectively treat bacterial ear infections, reducing symptoms, preventing complications, and supporting ear health. Benefits include rapid infection control, symptom relief, and prevention of further ear damage.
Ofloxacin ear drops is available in Ear drops
and strengths such as 0.3%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ofloxacin ear drops is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ofloxacin ear drops can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ofloxacin ear drops, marketed as Floxin Otic, are approved in the US by the FDA and in the EU via EMA for treating bacterial ear infections. Regulatory dossiers must include clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. For dossier preparation, regulatory pathways, and market access guidance, visit PharmaTradz. Proper adherence supports swift approval, safe administration, and global availability, enabling effective treatment of otitis media and external ear infections worldwide through high-quality, regionally approved ear drops.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing